Information  X 
Enter a valid email address

Reach PLC (RCH)

  Print      Mail a friend       Annual reports

Tuesday 24 December, 2019

Reach PLC

Director/PDMR Shareholding

RNS Number : 9662X
Reach PLC
24 December 2019
 

24 December 2019

 

Reach plc (the "Company")

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Anne Bulford

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Reach plc

b)

 

LEI

 

 

213800GNI5XF3XOATR61

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

Ordinary 10p Shares

 

 

Identification code

GB0009039941

 

 

b)

 

Nature of the transaction

 

 

Purchase of ordinary 10p shares.

c)

 

Price(s) and volume(s)

 

 

 

 

 

 

Price(s)

Volume(s)

 

 

 

£1.298

11,463

 

 

 

 

 

 

d)

 

Aggregated information

 

 

 

- Aggregated volume

N/A

 

 

- Price

N/A

 

 

e)

 

Date of the transaction

 

 

23 December 2019

f)

 

Place of the transaction

 

 

London Stock Exchange (XLON)

 

 

Enquiries

Reach plc

 

Jim Mullen, Chief Executive Officer

020 7293 3000

Simon Fuller, Chief Financial Officer and Company Secretary

 

 

Tulchan Communications

 

David Allchurch, Partner

020 7353 4200

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DSHKZLBLKLFBFBL

a d v e r t i s e m e n t